TREATMENT OF HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA WITH PRAVASTATIN (CS-514) AND OR CHOLESTYRAMINE - (THE SPANISH MULTICENTER PRAVASTATIN STUDY)

被引：0
|
作者：
CARMENA, R
DEOYA, M
FRANCO, M
MARTINEZ, M
MATA, P
GOMEZ, J
SERRANO, S
ALVAREZSALA, L
MATESANZ, J
RUBIO, M
GRAS, X
机构：
来源：
ATHEROSCLEROSIS VIII | 1989年 / 817卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：757 / 760
页数：4
相关论文
共 50 条
  • [41] Compliance with and efficacy of treatment with pravastatin and cholestyramine:: a randomized study on lipid-lowering in primary care
    Eriksson, M
    Hådell, K
    Holme, I
    Walldius, G
    Kjellström, T
    JOURNAL OF INTERNAL MEDICINE, 1998, 243 (05) : 373 - 380
  • [42] Multicenter Study to Determine the Diagnosis Criteria of Heterozygous Familial Hypercholesterolemia in Japan
    Harada-Shiba, Mariko
    Arai, Hidenori
    Okamura, Tomonori
    Yokote, Koutaro
    Oikawa, Shinichi
    Nohara, Atsushi
    Okada, Tomoo
    Ohta, Takao
    Bujo, Hideaki
    Watanabe, Makoto
    Wakatsuki, Akihiko
    Yamashita, Shizuya
    JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS, 2012, 19 (11) : 1019 - 1026
  • [43] EFFECT OF COMBINED TREATMENT WITH PRAVASTATIN, PROBUCOL, AND CHOLESTYLAMINE FOR CHOLESTEROL REDUCTION AND XANTHOMA REGRESSION IN PATIENTS WITH FAMILIAL HYPERCHOLESTEROLEMIA
    NAGAI, Y
    NAKAMURA, T
    TAKEMURA, K
    KUBO, M
    MATSUZAWA, Y
    TARUI, S
    ARTERIOSCLEROSIS, 1989, 9 (05): : A754 - A754
  • [44] Compliance with and efficacy of treatment with pravastatin and cholestyramine: A randomized study on lipid-lowering in primary care
    Eriksson, M
    Hadell, K
    Holme, I
    Walldius, G
    Kjellstrom, T
    ATHEROSCLEROSIS, 1997, 134 (1-2) : 55 - 55
  • [45] CHOLESTYRAMINE, GEMFIBROZIL, OR THEIR COMBINATION IN THE TREATMENT OF PATIENTS WITH FAMILIAL HYPERCHOLESTEROLEMIA - A RETROSPECTIVE STUDY
    GADDI, A
    CIARROCCHI, A
    BAROZZI, G
    DIGIULIO, R
    MUSSONI, C
    RIMONDI, S
    DESCOVICH, GC
    ADVANCES IN THERAPY, 1991, 8 (04) : 176 - 189
  • [46] INFLUENCE OF 3-HYDROXY-3-METHYLGLUTARYL COENZYME-A REDUCTASE INHIBITOR, PRAVASTATIN, ON CORTICOSTEROID METABOLISM IN PATIENTS WITH HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA
    TAKEDA, Y
    MIYAMORI, I
    KARAYALCIN, U
    TAKEDA, R
    HORMONE RESEARCH, 1991, 36 (1-2) : 75 - 77
  • [47] COMBINED TREATMENT WITH CHOLESTYRAMINE AND NICOTINIC-ACID IN HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA - EFFECTS ON BILIARY LIPID-COMPOSITION
    ANGELIN, B
    ERIKSSON, M
    EINARSSON, K
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 1986, 16 (05) : 391 - 396
  • [48] PRAVASTATIN IN HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA - LOW-DENSITY-LIPOPROTEIN (LDL) CHOLESTEROL-LOWERING EFFECT AND LDL RECEPTOR ACTIVITY ON SKIN FIBROBLASTS
    GADDI, A
    ARCA, M
    CIARROCCHI, A
    FAZIO, S
    DALO, G
    TIOZZO, R
    DESCOVICH, GC
    CALANDRA, S
    METABOLISM-CLINICAL AND EXPERIMENTAL, 1991, 40 (10): : 1074 - 1078
  • [49] CLEARANCE OF CHYLOMICRON-LIKE LIPID EMULSIONS IS INCREASED IN NORMAL RABBITS BUT NOT IN HETEROZYGOUS WATANABE HERITABLE HYPERLIPIDEMIC RABBITS FOLLOWING TREATMENT WITH CHOLESTYRAMINE OR PRAVASTATIN
    MAMO, JCL
    BOWLER, A
    REDGRAVE, TG
    ELSEGOOD, CL
    CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 1994, 21 (09) : 687 - 694
  • [50] LONG-TERM TREATMENT (2 YEARS) WITH THE HMG COA REDUCTASE INHIBITORS LOVASTATIN OR PRAVASTATIN IN COMBINATION WITH CHOLESTYRAMINE IN PATIENTS WITH SEVERE PRIMARY HYPERCHOLESTEROLEMIA
    JACOB, BG
    RICHTER, WO
    SCHWANDT, P
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1993, 22 (03) : 396 - 400
12345